William Blair Has Bearish Forecast for CRL Q1 Earnings

Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories International in a report released on Wednesday, February 19th. William Blair analyst M. Smock now expects that the medical research company will post earnings per share […]